Literature DB >> 8746253

Infrared imaging of sub-retinal structures in the human ocular fundus.

A E Elsner1, S A Burns, J J Weiter, F C Delori.   

Abstract

The interaction of infrared light with the human ocular fundus, particularly sub-retinal structures, was studied in vivo. Visible and infra-red wavelengths and a scanning laser ophthalmoscope were used to acquire digital images of the human fundus. The contrast and reflectance of selected retinal and sub-retinal features were computed for a series of wavelengths or modes of imaging. Near infrared light provides better visibility than visible light for sub-retinal features. Sub-retinal deposits appear light and thickened; the optic nerve head, retinal vessels, and choroidal vessels appear dark. Contrast and visibility of features increases with increasing wavelength from 795 to 895 nm. Optimizing the mode of imaging improves the visibility of some structures. This new quantitative basis for near infrared imaging techniques can be applied to a wide range of imaging modalities for the study of pathophysiology and treatment in diseases affecting the retinal pigment epithelium and Bruch's membrane, such as age-related macular degeneration.

Entities:  

Mesh:

Year:  1996        PMID: 8746253     DOI: 10.1016/0042-6989(95)00100-e

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  92 in total

1.  Cone photopigment in older subjects: decreased optical density in early age-related macular degeneration.

Authors:  Ann E Elsner; Stephen A Burns; John J Weiter
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2002-01       Impact factor: 2.129

2.  Differential imaging in scanning laser ophthalmoscopy.

Authors:  R A Ashman; F Reinholz; R H Eikelboom
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

3.  Decoding simulated neurodynamics predicts the perceptual consequences of age-related macular degeneration.

Authors:  Jianing V Shi; Jim Wielaard; R Theodore Smith; Paul Sajda
Journal:  J Vis       Date:  2011-12-05       Impact factor: 2.240

4.  Improved contrast of subretinal structures using polarization analysis.

Authors:  Stephen A Burns; Ann E Elsner; Mariane B Mellem-Kairala; Ruthanne B Simmons
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

Review 5.  Multimodal fundus imaging in fundus albipunctatus with RDH5 mutation: a newly identified compound heterozygous mutation and review of the literature.

Authors:  Nan-Kai Wang; Lan-Hsin Chuang; Chi-Chun Lai; Chai Lin Chou; Hsueh-Yen Chu; Ling Yeung; Yen-Po Chen; Kuan-Jen Chen; Wei-Chi Wu; Tun-Lu Chen; An-Ning Chao; Yih-Shiou Hwang
Journal:  Doc Ophthalmol       Date:  2012-06-06       Impact factor: 2.379

6.  In vivo adaptive optics microvascular imaging in diabetic patients without clinically severe diabetic retinopathy.

Authors:  Stephen A Burns; Ann E Elsner; Toco Y Chui; Dean A Vannasdale; Christopher A Clark; Thomas J Gast; Victor E Malinovsky; Anh-Danh T Phan
Journal:  Biomed Opt Express       Date:  2014-02-27       Impact factor: 3.732

7.  Spectral imaging of the area of internal limiting membrane peeling.

Authors:  Masahiro Miura; Ann E Elsner; Masahiro Osako; Kunio Yamada; Tetsuya Agawa; Masahiko Usui; Takuya Iwasaki
Journal:  Retina       Date:  2005-06       Impact factor: 4.256

8.  Large-field-of-view, modular, stabilized, adaptive-optics-based scanning laser ophthalmoscope.

Authors:  Stephen A Burns; Remy Tumbar; Ann E Elsner; Daniel Ferguson; Daniel X Hammer
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

9.  Imaging polarimetry and retinal blood vessel quantification at the epiretinal membrane.

Authors:  Masahiro Miura; Ann E Elsner; Michael C Cheney; Masahiko Usui; Takuya Iwasaki
Journal:  J Opt Soc Am A Opt Image Sci Vis       Date:  2007-05       Impact factor: 2.129

10.  Assessing macular pigment from SLO images.

Authors:  Rajeev Seth; Peter Gouras
Journal:  Doc Ophthalmol       Date:  2004-05       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.